{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:24:46Z","timestamp":1762100686748},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2003,7,1]],"date-time":"2003-07-01T00:00:00Z","timestamp":1057017600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Psychiatry Rep"],"published-print":{"date-parts":[[2003,7]]},"DOI":"10.1007\/s11920-003-0054-9","type":"journal-article","created":{"date-parts":[[2007,6,2]],"date-time":"2007-06-02T06:53:01Z","timestamp":1180767181000},"page":"252-265","source":"Crossref","is-referenced-by-count":7,"title":["Childhood anxiety disorders and developmental issues in anxiety"],"prefix":"10.1007","volume":"5","author":[{"given":"Paul","family":"Arnold","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Preeya","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rashmi","family":"Bhandari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Ivey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Rose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R.","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"54_CR1","first-page":"273","volume-title":"Anxiety Disorders in Children and Adolescents: Research, Assessment and Intervention","author":"F Verhulst","year":"2001","unstructured":"Verhulst F: Community and epidemiological aspects of anxiety disorders in children. In Anxiety Disorders in Children and Adolescents: Research, Assessment and Intervention. Edited by Silverman W, Treffers P. Cambridge: Cambridge University Press; 2001:273\u2013292."},{"key":"54_CR2","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2000","unstructured":"American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, edn 4, Text Revision. Washington, DC: American Psychiatric Association; 2000.","edition":"edn 4"},{"key":"54_CR3","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0272-7358(99)00034-3","volume":"20","author":"E Gullone","year":"2000","unstructured":"Gullone E: The development of normal fear: a century of research. Clin Psychol Rev 2000, 20:429\u2013451.","journal-title":"Clin Psychol Rev"},{"key":"54_CR4","first-page":"821","volume-title":"Child and Adolescent Psychiatry: A Comprehensive Textbook","author":"J Freeman","year":"2002","unstructured":"Freeman J, Garcia A, Leonard H: Anxiety disorders. In Child and Adolescent Psychiatry: A Comprehensive Textbook. Edited by Lewis M. Philadelphia: Lippincott Williams & Wilkins; 2002:821\u2013834."},{"key":"54_CR5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2165\/00023210-200115020-00002","volume":"15","author":"G Masi","year":"2001","unstructured":"Masi G, Mucci M, Millepiedi S: Separation anxiety disorder in children and adolescents: epidemiology, diagnosis and management. CNS Drugs 2001, 15:93\u2013104.","journal-title":"CNS Drugs"},{"key":"54_CR6","volume-title":"Anxiety Disorders in Children and Adolescents: Research, Assessment and Intervention","author":"L-G Ost","year":"2001","unstructured":"Ost L-G, Treffers P: Onset, course and outcome for anxiety disorders in children. In Anxiety Disorders in Children and Adolescents: Research, Assessment and Intervention. Edited by Silverman W, Treffers P. Cambridge: Cambridge University Press; 2001."},{"key":"54_CR7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0010-440X(96)90033-4","volume":"37","author":"D Silove","year":"1996","unstructured":"Silove D, Manicavasagar V, Curtis J, Blaszczynski A: Is early separation anxiety a risk factor for adult panic disorder? A critical review. Compr Psychiatry 1996, 37:167\u2013179.","journal-title":"Compr Psychiatry"},{"key":"54_CR8","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1001\/archpsyc.57.10.960","volume":"57","author":"DS Pine","year":"2000","unstructured":"Pine DS, Klein RG, Coplan JD, et al.: Differential carbon dioxide sensitivity in childhood anxiety disorders and nonill comparison group. Arch Gen Psychiatry 2000, 57:960\u2013967.","journal-title":"Arch Gen Psychiatry"},{"key":"54_CR9","doi-asserted-by":"crossref","unstructured":"Slattery MJ, Klein DF, Mannuzza S, et al.: Relationship between separation anxiety disorder, parental panic disorder, and atopic disorders in children: a controlled high-risk study. J Am Acad Child Adolesc Psychiatry 2002, 41947\u2013954.","DOI":"10.1097\/00004583-200208000-00013"},{"key":"54_CR10","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1001\/archpsyc.59.3.242","volume":"59","author":"KS Kendler","year":"2002","unstructured":"Kendler KS, Myers J, Prescott CA: The etiology of phobias: an evaluation of the stress-diathesis model. Arch Gen Psychiatry 2002, 59:242\u2013248.","journal-title":"Arch Gen Psychiatry"},{"key":"54_CR11","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1097\/00004583-199611000-00011","volume":"35","author":"B Birmaher","year":"1996","unstructured":"Birmaher B, Ryan ND, Williamson DE, et al.: Childhood and adolescent depression: a review of the past 10 years: part I. J Am Acad Child Adolesc Psychiatry 1996, 35:1427\u20131439.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"54_CR12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/archpsyc.55.1.56","volume":"55","author":"DS Pine","year":"1998","unstructured":"Pine DS, Cohen P, Gurley D, et al.: The risk for early-adulthood anxiety and depressive disorders in adolescents with anxiety and depressive disorders. Arch Gen Psychiatry 1998, 55:56\u201364.","journal-title":"Arch Gen Psychiatry"},{"key":"54_CR13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/da.1048","volume":"14","author":"DA Axelson","year":"2001","unstructured":"Axelson DA, Birmaher B: Relation between anxiety and depressive disorders in childhood and adolescence. Depress Anxiety 2001, 14:67\u201378.","journal-title":"Depress Anxiety"},{"key":"54_CR14","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1097\/00004583-199908000-00017","volume":"38","author":"CE Schwartz","year":"1999","unstructured":"Schwartz CE, Snidman N, Kagan J: Adolescent social anxiety as an outcome of inhibited temperament in childhood. J Am Acad Child Adolesc Psychiatry 1999, 38:1008\u20131015.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"54_CR15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/comp.2002.29848","volume":"43","author":"RD Goodwin","year":"2002","unstructured":"Goodwin RD, Hamilton SP: Early-onset fearful panic attack: a possible prodrome of early-onset severe psychopathology. Compr Psychiatry 2002, 43:22\u201327.","journal-title":"Compr Psychiatry"},{"key":"54_CR16","first-page":"23","volume":"62","author":"W Yule","year":"2001","unstructured":"Yule W: Posttraumatic stress disorder in the general population and in children. J Clin Psychiatry 2001, 62(suppl):23\u201328.","journal-title":"J Clin Psychiatry"},{"key":"54_CR17","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1176\/ajp.156.10.1536","volume":"156","author":"L Terr","year":"1999","unstructured":"Terr L: Children\u2019s symptoms in the wake of Challenger: a field study of distant-traumatic events and an outline of related conditions. Am J Psychiatry 1999, 156:1536\u20131544.","journal-title":"Am J Psychiatry"},{"key":"54_CR18","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3109\/10673229809000309","volume":"5","author":"D Geller","year":"1998","unstructured":"Geller D, Biederman J, Jones J, et al.: Obsessive-compulsive disorder in children and adolescents: a review. Harv Rev Psychiatry 1998, 5:260\u2013273.","journal-title":"Harv Rev Psychiatry"},{"key":"54_CR19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0272-7358(99)00044-6","volume":"21","author":"J Eichstedt","year":"2001","unstructured":"Eichstedt J, Arnold S: Childhood-onset obsessive-compulsive disorder: a tic-related subtype of OCD? Clin Psychol Rev 2001, 21:137\u2013158.","journal-title":"Clin Psychol Rev"},{"key":"54_CR20","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00005053-200107000-00009","volume":"189","author":"D Geller","year":"2001","unstructured":"Geller D, Biederman J, Faraone S, et al.: Developmental aspects of obsessive-compulsive disorder: findings in children, adolescents, and adults. J Nerv Ment Dis 2001, 189:471\u2013477.","journal-title":"J Nerv Ment Dis"},{"key":"54_CR21","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1176\/ajp.155.8.1122","volume":"155","author":"FR Asbahr","year":"1998","unstructured":"Asbahr FR, Negrao AB, Gentil V, et al.: Obsessive-compulsive and related symptoms in children and adolescents with rheumatic fever with and without chorea: a prospective 6-month study. Am J Psychiatry 1998, 155:1122\u20131124.","journal-title":"Am J Psychiatry"},{"key":"54_CR22","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1038\/sj.mp.4001170","volume":"7","author":"S Swedo","year":"2001","unstructured":"Swedo S: Immunology of neurodevelopmental disorders: pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS). Mol Psychiatry 2001, 7:S24-S25.","journal-title":"Mol Psychiatry"},{"key":"54_CR23","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/archpedi.156.4.356","volume":"156","author":"M Murphy","year":"2002","unstructured":"Murphy M, Pichichero M: Prospective identification and treatment of children with Pediatric Autoimmune Neuropsychiatric Disorder Associated with Group A Streptococcal Infection (PANDAS). Arch Pediatr Adolesc Med 2002, 156:356\u2013361.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"54_CR24","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1097\/00004583-200009000-00011","volume":"39","author":"L Lougee","year":"2000","unstructured":"Lougee L, Perlmutter S, Nicolson R, et al.: Psychiatric disorders in first-degree relatives of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS). J Am Acad Child Adolesc Psychiatry 2000, 39:1120\u20131126.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"54_CR25","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/1469-7610.00798","volume":"42","author":"MR Dadds","year":"2001","unstructured":"Dadds MR, Barrett PM: Practitioner review: psychological management of anxiety disorders in childhood. J Child Psychol Psychiatry 2001, 42:999\u20131011.","journal-title":"J Child Psychol Psychiatry"},{"key":"54_CR26","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1097\/00004583-199910000-00010","volume":"38","author":"SL Mendlowitz","year":"1999","unstructured":"Mendlowitz SL, Manassis K, Bradley S, et al.: Cognitive-behavioral group treatments in childhood anxiety disorders: the role of parental involvement. J Am Acad Child Adolesc Psychiatry 1999, 38:1223\u20131229.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"54_CR27","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1097\/00004583-200212000-00013","volume":"41","author":"K Manassis","year":"2002","unstructured":"Manassis K, Mendlowitz SL, Scapillato D, et al.: Group and individual cognitive-behavioral therapy for childhood anxiety disorders: a randomized trial. J Am Acad Child Adolesc Psychiatry 2002, 41:1423\u20131430.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"54_CR28","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1176\/appi.ajp.158.10.1568","volume":"158","author":"JM Hettema","year":"2001","unstructured":"Hettema JM, Neale MC, Kendler KS: A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry 2001, 158:1568\u20131578.","journal-title":"Am J Psychiatry"},{"key":"54_CR29","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1037\/0022-006X.66.6.893","volume":"66","author":"VE Cobham","year":"1998","unstructured":"Cobham VE, Dadds MR, Spence SH: The role of parental anxiety in the treatment of childhood anxiety. J Consult Clin Psychol 1998, 66:893\u2013905.","journal-title":"J Consult Clin Psychol"},{"key":"54_CR30","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/jclp.10030","volume":"58","author":"JL Hudson","year":"2002","unstructured":"Hudson JL, Kendall PC: Showing you can do it: homework in therapy for children and adolescents with anxiety disorders. J Clin Psychol 2002, 58:525\u2013534.","journal-title":"J Clin Psychol"},{"key":"54_CR31","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0272-7358(99)00038-0","volume":"20","author":"PM Barrett","year":"2000","unstructured":"Barrett PM: Treatment of childhood anxiety: developmental aspects. Clin Psychol Rev 2000, 20:479\u2013494.","journal-title":"Clin Psychol Rev"},{"key":"54_CR32","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00004583-199804000-00017","volume":"37","author":"NJ King","year":"1998","unstructured":"King NJ, Tonge BJ, Heyne D, et al.: Cognitive-behavioral treatment of school-refusing children: a controlled evaluation. J Am Acad Child Adolesc Psychiatry 1998, 37:395\u2013403.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"54_CR33","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1037\/0022-006X.67.5.675","volume":"67","author":"WK Silverman","year":"1999","unstructured":"Silverman WK, Kurtines WM, Ginsburg GS, et al.: Contingency management, self-control, and education support in the treatment of childhood phobic disorders: a randomized clinical trial. J Consult Clin Psychol 1999, 67:675\u2013687.","journal-title":"J Consult Clin Psychol"},{"key":"54_CR34","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00004583-200303000-00013","volume":"42","author":"E Leger","year":"2003","unstructured":"Leger E, Ladouceur R, Dugas MJ, Freeston MH: Cognitivebehavioral treatment of generalized anxiety disorder among adolescents: a case series. J Am Acad Child Adolesc Psychiatry 2003, 42:327\u2013330.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"54_CR35","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/00004583-200006000-00010","volume":"39","author":"C Hayward","year":"2000","unstructured":"Hayward C, Varady S, Albano AM, et al.: Cognitive-behavioral group therapy for social phobia in female adolescents: results of a pilot study. J Am Acad Child Adolesc Psychiatry 2000, 39:721\u2013726.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"54_CR36","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1037\/0022-006X.68.6.1072","volume":"68","author":"DC Beidel","year":"2000","unstructured":"Beidel DC, Turner SM, Morris TL: Behavioral treatment of childhood social phobia. J Consult Clin Psychol 2000, 68:1072\u20131080.","journal-title":"J Consult Clin Psychol"},{"key":"54_CR37","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/1469-7610.00659","volume":"41","author":"SH Spence","year":"2000","unstructured":"Spence SH, Donovan C, Brechman-Toussaint M: The treatment of childhood social phobia: the effectiveness of a social skills training-based, cognitive-behavioral intervention, with and without parental involvement. J Child Psychol Psychiatry 2000, 41:713\u2013726.","journal-title":"J Child Psychol Psychiatry"},{"key":"54_CR38","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0005-7894(05)80098-X","volume":"26","author":"T Ollendick","year":"1995","unstructured":"Ollendick T: Cognitive-behavioral treatment of panic disorder with agoraphobia in adolescents: a multiple baseline design analysis. Behav Ther 1995, 26:517\u2013531.","journal-title":"Behav Ther"},{"key":"54_CR39","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0006-3223(01)01352-X","volume":"51","author":"DS Pine","year":"2002","unstructured":"Pine DS, Cohen JA: Trauma in children and adolescents: risk and treatment of psychiatric sequelae. Biol Psychiatry 2002, 51:519\u2013531.","journal-title":"Biol Psychiatry"},{"key":"54_CR40","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/00004583-199806000-00008","volume":"37","author":"JS March","year":"1998","unstructured":"March JS, Amaya-Jackson L, Murray MC, Schulte A: Cognitivebehavioral psychotherapy for children and adolescents with posttraumatic stress disorder after a single-incident stressor. J Am Acad Child Adolesc Psychiatry 1998, 37:585\u2013593.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"54_CR41","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1207\/S15374424JCCP3001_3","volume":"30","author":"JS March","year":"2001","unstructured":"March JS, Franklin M, Nelson A, Foa E: Cognitive-behavioral psychotherapy for pediatric obsessive-compulsive disorder. J Clin Child Psychol 2001, 30:8\u201318.","journal-title":"J Clin Child Psychol"},{"key":"54_CR42","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0005-7967(01)00064-X","volume":"40","author":"NR Benazon","year":"2002","unstructured":"Benazon NR, Ager J, Rosenberg DR: Cognitive behavior therapy in treatment-naive children and adolescents with obsessive-compulsive disorder: an open trial. Behav Res Ther 2002, 40:529\u2013539.","journal-title":"Behav Res Ther"},{"key":"54_CR43","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/00004583-199804000-00019","volume":"37","author":"ME Franklin","year":"1998","unstructured":"Franklin ME, Kozak MJ, Cashman LA, et al.: Cognitive-behavioral treatment of pediatric obsessive-compulsive disorder: an open clinical trial. J Am Acad Child Adolesc Psychiatry 1998, 37:412\u2013419.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"54_CR44","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00004583-199403000-00006","volume":"33","author":"JS March","year":"1994","unstructured":"March JS, Mulle K, Herbel B: Behavioral psychotherapy for children and adolescents with obsessive-compulsive disorder: an open trial of a new protocol-driven treatment package. J Am Acad Child Adolesc Psychiatry 1994, 33:333\u2013341.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"54_CR45","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0887-6185(02)00096-8","volume":"16","author":"J Piacentini","year":"2002","unstructured":"Piacentini J, Bergman RL, Jacobs C, et al.: Open trial of cognitive behavior therapy for childhood obsessive-compulsive disorder. J Anxiety Disord 2002, 16:207\u2013219.","journal-title":"J Anxiety Disord"},{"key":"54_CR46","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3109\/00048679709073806","volume":"31","author":"C Wever","year":"1997","unstructured":"Wever C, Rey JM: Juvenile obsessive-compulsive disorder. Aust N Z J Psychiatry 1997, 31:105\u2013113.","journal-title":"Aust N Z J Psychiatry"},{"key":"54_CR47","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1097\/00004583-200111000-00004","volume":"40","author":"M Thienemann","year":"2001","unstructured":"Thienemann M, Martin J, Cregger B, et al.: Manual-driven group cognitive-behavioral therapy for adolescents with obsessive-compulsive disorder: a pilot study. J Am Acad Child Adolesc Psychiatry 2001, 40:1254\u20131260.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"54_CR48","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1176\/appi.psychotherapy.2001.55.3.372","volume":"55","author":"TL Waters","year":"2001","unstructured":"Waters TL, Barrett PM, March JS: Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: preliminary findings. Am J Psychother 2001, 55:372\u2013387.","journal-title":"Am J Psychother"},{"key":"54_CR49","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0005-7967(02)00011-6","volume":"41","author":"PM Barrett","year":"2003","unstructured":"Barrett PM, Healy LJ: An examination of the cognitive processes involved in childhood obsessive-compulsive disorder. Behav Res Ther 2003, 41:285\u2013299.","journal-title":"Behav Res Ther"},{"key":"54_CR50","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00004583-200303000-00014","volume":"42","author":"F Muratori","year":"2003","unstructured":"Muratori F, Picchi L, Bruni G, et al.: A two-year follow-up of psychodynamic psychotherapy for internalizing disorders in children. J Am Acad Child Adolesc Psychiatry 2003, 42:331\u2013339.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"54_CR51","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1201\/9780203909294","volume-title":"Pharmacotherapy for Child and Adolescent Psychiatric Disorders","author":"D Rosenberg","year":"2002","unstructured":"Rosenberg D: Selective serotonin reuptake inhibitors. In Pharmacotherapy for Child and Adolescent Psychiatric Disorders. Edited by Rosenberg D, Davanzo P, Gershon S. New York: Marcel Dekker; 2002:223\u2013296."},{"key":"54_CR52","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJM200104263441703","volume":"344","author":"Research Unit on Pediatric Psychopharmacology Anxiety Study Group","year":"2001","unstructured":"Research Unit on Pediatric Psychopharmacology Anxiety Study Group: Fluvoxamine for the treatment of anxiety disorders in children and adolescents. N Engl J Med 2001, 344:1279\u20131285. This study of fluvoxamine treatment in 128 subjects diagnosed with GAD, SAD, or social phobia represents the first multicenter randomized controlled trial of a pharmacologic treatment in children with these anxiety disorders. Using sound methodology, the study authors demonstrated fluvoxamine as a highly efficacious (76% response rate) and well-tolerated treatment.","journal-title":"N Engl J Med"},{"key":"54_CR53","first-page":"10","volume":"28","author":"G Borzo","year":"2000","unstructured":"Borzo G: Fluvoxamine treats anxiety in children, teens. Clin Psychiatry News 2000, 28:10.","journal-title":"Clin Psychiatry News"},{"key":"54_CR54","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1089\/104454602760386879","volume":"12","author":"J Walkup","year":"2002","unstructured":"Walkup J, Labellarte M, Riddle MA, et al.: Treatment of pediatric anxiety disorders: an open-label extension of the research units on pediatric psychopharmacology anxiety study. J Child Adolesc Psychopharmacol 2002, 12:175\u2013188.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"54_CR55","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00004583-200301000-00006","volume":"42","author":"JT Walkup","year":"2003","unstructured":"Walkup JT, Labellarte MJ, Riddle MA, et al.: Searching for moderators and mediators of pharmacological treatment effects in children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry 2003, 42:13\u201321. This report describes moderators and mediators of treatment effects in the Research Unit on Pediatric Psychopharmacology study [52]. Predictors of positive response included decreased levels of depression, whereas negative response was predicted by presence of social phobia and increased illness severity. A better understanding of predictors of response will help clinicians in deciding the treatment option that is best suited to an individual patient.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"54_CR56","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1176\/appi.ajp.158.12.2008","volume":"158","author":"MA Rynn","year":"2001","unstructured":"Rynn MA, Siqueland L, Rickels K: Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder. Am J Psychiatry 2001, 158:2008\u20132014.","journal-title":"Am J Psychiatry"},{"key":"54_CR57","first-page":"91","volume-title":"Scientific proceedings of the 49th Annual Meeting of the American Academy of Child and Adolescent Psychiatry","author":"M Rynn","year":"2002","unstructured":"Rynn M, Kunz N, Lamm L, et al.: Venlafaxine XR for treatment of GAD in children and adolescents. Scientific proceedings of the 49th Annual Meeting of the American Academy of Child and Adolescent Psychiatry. San Francisco: American Academy of Child and Adolescent Psychiatry; 2002:91."},{"key":"54_CR58","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/00004583-200105000-00016","volume":"40","author":"SN Compton","year":"2001","unstructured":"Compton SN, Grant PJ, Chrisman AK, et al.: Sertraline in children and adolescents with social anxiety disorder: an open trial. J Am Acad Child Adolesc Psychiatry 2001, 40:564\u2013571.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"54_CR59","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1089\/10445460252943560","volume":"12","author":"DA Chavira","year":"2002","unstructured":"Chavira DA, Stein MB: Combined psychoeducation and treatment with selective serotonin reuptake inhibitors for youth with generalized social anxiety disorder. J Child Adolesc Psychopharmacol 2002, 12:47\u201354.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"54_CR60","first-page":"95","volume-title":"Scientific proceedings of the 49th Annual Meeting of the American Academy of Child and Adolescent Psychiatry","author":"K Wagner","year":"2002","unstructured":"Wagner K, Stein M, Berard R, et al.: Efficacy of paroxetine in childhood and adolescent social anxiety disorder. Scientific proceedings of the 49th Annual Meeting of the American Academy of Child and Adolescent Psychiatry. San Francisco: American Academy of Child and Adolescent Psychiatry; 2002:95."},{"key":"54_CR61","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1089\/104454601750284054","volume":"11","author":"G Masi","year":"2001","unstructured":"Masi G, Toni C, Mucci M, et al.: Paroxetine in children and adolescent outpatients with panic disorder. J Child Adolesc Psychopharmacol 2001, 11:151\u2013157.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"54_CR62","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0145-2134(00)00226-X","volume":"25","author":"JA Cohen","year":"2001","unstructured":"Cohen JA, Mannarino AP, Rogal S: Treatment practices for childhood posttraumatic stress disorder. Child Abuse Negl 2001, 25:123\u2013135.","journal-title":"Child Abuse Negl"},{"key":"54_CR63","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1089\/10445460252943551","volume":"12","author":"S Seedat","year":"2002","unstructured":"Seedat S, Stein DJ, Ziervogel C, et al.: Comparison of response to a selective serotonin reuptake inhibitor in children, adolescents, and adults with posttraumatic stress disorder. J Child Adolesc Psychopharmacol 2002, 12:37\u201346.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"54_CR64","first-page":"2","volume":"58","author":"J March","year":"1997","unstructured":"March J, Frances A, Carpenter D, et al.: Treatment of obsessivecompulsive disorder: the Expert Consensus Panel for obsessive-compulsive disorder. J Clin Psychiatry 1997, 58(suppl):2\u201372.","journal-title":"J Clin Psychiatry"},{"key":"54_CR65","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/(SICI)1520-6394(1998)8:1+<105::AID-DA16>3.0.CO;2-T","volume":"8","author":"C Cartwright","year":"1998","unstructured":"Cartwright C, Hollander E: SSRIs in the treatment of obsessive-compulsive disorder. Depress Anxiety 1998, 8(suppl):105\u2013113.","journal-title":"Depress Anxiety"},{"key":"54_CR66","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1586\/14737175.2.6.783","volume":"2","author":"J Ivey","year":"2002","unstructured":"Ivey J, Rosenberg DR: Clomipramine use in obsessive-compulsive disorder. Expert Rev Neurotherapeutics 2002, 2:783\u2013790.","journal-title":"Expert Rev Neurotherapeutics"},{"key":"54_CR67","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/00004583-200102000-00017","volume":"40","author":"MA Riddle","year":"2001","unstructured":"Riddle MA, Reeve EA, Yaryura-Tobias JA, et al.: Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial. J Am Acad Child Adolesc Psychiatry 2001, 40:222\u2013229.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"54_CR68","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1001\/jama.280.20.1752","volume":"280","author":"JS March","year":"1998","unstructured":"March JS, Biederman J, Wolkow R, et al.: Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial. JAMA 1998, 280:1752\u20131756.","journal-title":"JAMA"},{"key":"54_CR69","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/00004583-200107000-00011","volume":"40","author":"DA Geller","year":"2001","unstructured":"Geller DA, Hoog SL, Heiligenstein JH, et al.: Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: a placebo-controlled clinical trial. J Am Acad Child Adolesc Psychiatry 2001, 40:773\u2013779.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"54_CR70","first-page":"117","volume-title":"Scientific proceedings of the 49th Annual Meeting of the American Academy of Child and Adolescent Psychiatry","author":"D Geller","year":"2002","unstructured":"Geller D, Wagner K, Emslie G, et al.: Efficacy of paroxetine in pediatric OCD: results of a multicenter study. Scientific proceedings of the 49th Annual Meeting of the American Academy of Child and Adolescent Psychiatry. San Francisco: American Academy of Child and Adolescent Psychiatry; 2002:117."},{"key":"54_CR71","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/00004583-200108000-00010","volume":"40","author":"PH Thomsen","year":"2001","unstructured":"Thomsen PH, Ebbesen C, Persson C: Long-term experience with citalopram in the treatment of adolescent OCD. J Am Acad Child Adolesc Psychiatry 2001, 40:895\u2013902.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"54_CR72","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1001\/archpsyc.1995.03950160039008","volume":"52","author":"J Greist","year":"1995","unstructured":"Greist J, Chouinard G, DuBoff E, et al.: Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder. Arch Gen Psychiatry 1995, 52:289\u2013295.","journal-title":"Arch Gen Psychiatry"},{"key":"54_CR73","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1097\/00004583-199908000-00010","volume":"38","author":"RL Findling","year":"1999","unstructured":"Findling RL, Reed MD, Myers C, et al.: Paroxetine pharmacokinetics in depressed children and adolescents. J Am Acad Child Adolesc Psychiatry 1999, 38:952\u2013959.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"54_CR74","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1001\/archpsyc.57.8.794","volume":"57","author":"CJ McDougle","year":"2000","unstructured":"McDougle CJ, Epperson CN, Pelton GH, et al.: A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. Arch Gen Psychiatry 2000, 57:794\u2013801.","journal-title":"Arch Gen Psychiatry"},{"key":"54_CR75","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1089\/cap.1999.9.115","volume":"9","author":"KD Fitzgerald","year":"1999","unstructured":"Fitzgerald KD, Stewart CM, Tawile V, Rosenberg DR: Risperidone augmentation of serotonin reuptake inhibitor treatment of pediatric obsessive compulsive disorder. J Child Adolesc Psychopharmacol 1999, 9:115\u2013123.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"54_CR76","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0924-9338(02)00673-9","volume":"17","author":"M Crocq","year":"2002","unstructured":"Crocq M, Leclerq P, Guillon M, Bailey P: Open-label olanzapine in obsessive-compulsive disorder refractory to antidepressant treatment. Eur Psychiatry 2002, 17:296\u2013297.","journal-title":"Eur Psychiatry"},{"key":"54_CR77","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1001\/archpsyc.1994.03950040046006","volume":"51","author":"CJ McDougle","year":"1994","unstructured":"McDougle CJ, Goodman WK, Leckman JF, et al.: Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder: a double-blind, placebo-controlled study in patients with and without tics. Arch Gen Psychiatry 1994, 51:302\u2013308.","journal-title":"Arch Gen Psychiatry"},{"key":"54_CR78","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1089\/cap.1998.8.61","volume":"8","author":"Y Figueroa","year":"1998","unstructured":"Figueroa Y, Rosenberg DR, Birmaher B, Keshavan MS: Combination treatment with clomipramine and selective serotonin reuptake inhibitors for obsessive-compulsive disorder in children and adolescents. J Child Adolesc Psychopharmacol 1998, 8:61\u201367.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"54_CR79","first-page":"277","volume-title":"Obsessive-compulsive Disorder: Contemporary Issues in Treatment","author":"T Pigott","year":"2000","unstructured":"Pigott T, Sheay S: Pharmacotherapy of obsessive-compulsive disorder: overview and treatment-refractory strategies. In Obsessive-compulsive Disorder: Contemporary Issues in Treatment. Edited by Goodman W, Rudorfer M, Maser J. Mahwah: Lawrence Erlbaum Associates; 2000:277\u2013302."},{"key":"54_CR80","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1097\/00004583-200009000-00008","volume":"39","author":"D Rosenberg","year":"2000","unstructured":"Rosenberg D, MacMaster F, Keshavan M, et al.: Decrease in caudate glutamatergic concentrations in pediatric obsessivecompulsive disorder patients taking paroxetine. J Am Acad Child Adolesc Psychiatry 2000, 39:1096\u20131103.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"54_CR81","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0006-3223(97)00443-5","volume":"43","author":"D Rosenberg","year":"1998","unstructured":"Rosenberg D: Toward a neuroodevelopmental model of obsessive-compulsive disorder. Biol Psychiatry 1998, 43:623\u2013640.","journal-title":"Biol Psychiatry"},{"key":"54_CR82","first-page":"118","volume-title":"Scientific proceedings of the 49th Annual Meeting of the American Academy of Child and Adolescent Psychiatry.","author":"P Arnold","year":"2002","unstructured":"Arnold P, Mundo E, Richter M, et al.: Are NMDA genes linked to early onset obsessive-compulsive disorder? Scientific proceedings of the 49th Annual Meeting of the American Academy of Child and Adolescent Psychiatry. San Francisco: American Academy of Child and Adolescent Psychiatry; 2002:118."},{"key":"54_CR83","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/S0006-3223(00)01073-8","volume":"48","author":"D Rosenberg","year":"2000","unstructured":"Rosenberg D, Hanna G: Genetic and imaging strategies in obsessive-compulsive disorder: potential implications for treatment development. Biol Psychiatry 2000, 48:1210\u20131222.","journal-title":"Biol Psychiatry"},{"key":"54_CR84","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/S0006-3223(99)00020-7","volume":"45","author":"M Garvey","year":"1999","unstructured":"Garvey M, Perlmutter S, Allen A, et al.: A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections. Biol Psychiatry 1999, 45:1564\u20131571.","journal-title":"Biol Psychiatry"},{"key":"54_CR85","first-page":"1353","volume":"165","author":"P Arnold","year":"2001","unstructured":"Arnold P, Richter M: Is obsessive-compulsive disorder an autoimmune disease? Can J Psychiatry 2001, 165:1353\u20131358.","journal-title":"Can J Psychiatry"},{"key":"54_CR86","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0140-6736(98)12297-3","volume":"354","author":"S Perlmutter","year":"1999","unstructured":"Perlmutter S, Leitman S, Garvey M, et al.: Therapeutic plasma exchange and intravenous immunoglobulin for obsessivecompulsive disorder and tic disorders in childhood. Lancet 1999, 354:1153\u20131158.","journal-title":"Lancet"},{"key":"54_CR87","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1097\/00004583-200010000-00020","volume":"39","author":"R Nicolson","year":"2000","unstructured":"Nicolson R, Swedo S, Lenane M, et al.: An open trial of plasma exchange in childhood-onset obsessive-compulsive disorder without post-streptococcal exacerbations. J Am Acad Child Adolesc Psychiatry 2000, 39:1313\u20131315.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"54_CR88","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1097\/00004583-200110000-00011","volume":"40","author":"EH Cook","year":"2001","unstructured":"Cook EH, Wagner KD, March JS, et al.: Long-term sertraline treatment of children and adolescents with obsessivecompulsive disorder. J Am Acad Child Adolesc Psychiatry 2001, 40:1175\u20131181. The efficacy and tolerability of sertraline was studied over a 1-year period in 137 children or adolescents with OCD after completion of a controlled trial. Significant improvement was observed during the extension period in responders to the acute trial, and 43% of individuals who did not respond in the 12 week trial were classified as responders at the end of 1 year. Long-term effects of SSRIs are becoming an increasingly important question as more children are treated for longer periods with these medications.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"54_CR89","doi-asserted-by":"crossref","unstructured":"Wagner K, Cook E, Chugn H, et al.: Remission status after long-term sertraline treatment of pediatric OCD. J Child Adolesc Psychopharmacol 2003, in press.","DOI":"10.1089\/104454603322126340"},{"key":"54_CR90","unstructured":"Gallagher D, Gardiner C, Carpenter D: Interim results: long-term safety of paroxetine in pediatric patients. New Research Program and Abstract presented at the 155th Annual Meeting of the American Psychiatric Association. Philadelphia, PA; May 10\u201314, 2002."},{"key":"54_CR91","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1001\/archpedi.156.7.696","volume":"156","author":"N Weintrob","year":"2002","unstructured":"Weintrob N, Cohen D, Klipper-Aurbach Y, et al.: Decreased growth during therapy with selective serotonin reuptake inhibitors. Arch Pediatr Adolesc Med 2002, 156:696\u2013701.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"54_CR92","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1201\/9780203909294","volume-title":"Pharmacotherapy for Child and Adolescent Psychiatric Disorders","author":"D Rosenberg","year":"2002","unstructured":"Rosenberg D: Anxiolytics. In Pharmacotherapy for Child and Adolescent Psychiatric Disorders. Edited by Rosenberg D, Davanzo P, Gershon S. New York: Marcel Dekker; 2002:489\u2013541."},{"key":"54_CR93","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1201\/9780203909294","volume-title":"Pharmacotherapy for Child and Adolescent Psychiatric Disorders","author":"D Rosenberg","year":"2002","unstructured":"Rosenberg D: Tricyclic antidepressants. In Pharmacotherapy for Child and Adolescent Psychiatric Disorders. Edited by Rosenberg D, Davanzo P, Gershon S. New York: Marcel Dekker, 2002:169\u2013222."},{"key":"54_CR94","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00004583-200003000-00008","volume":"39","author":"GA Bernstein","year":"2000","unstructured":"Bernstein GA, Borchardt CM, Perwien AR, et al.: Imipramine plus cognitive-behavioral therapy in the treatment of school refusal. J Am Acad Child Adolesc Psychiatry 2000, 39:276\u2013283. In this randomized controlled trial, 63 children meeting criteria for major depressive disorder and one or more anxiety disorders were randomized to receive CBT with placebo or CBT with imipramine. Significant improvement in school attendance was demonstrated in the imipramine plus CBT group, but not in the CBT plus placebo group, whereas anxiety and depression decreased in the groups. Application of study findings are limited by the use of tricyclic antidepressants, now considered second-line agents in child anxiety disorders; however, it remains important because it is the only published randomized controlled trial demonstrating the increased benefits of combining CBT with pharmacotherapy.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"54_CR95","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00004583-200303000-00012","volume":"42","author":"A Layne","year":"2003","unstructured":"Layne A, Bernstein G, Egan E, Kushner M: Predictors of treatment response in anxious-depressed adolescents with school refusal. J Am Acad Child Adolesc Psychiatry 2003, 42:319\u2013326. This report of predictors of treatment response in the Bernstein et al. study [94] indicated that positive response to treatment was predicted by use of imipramine and improved attendance at baseline. Predictors of poor response include the presence of SAD or avoidant disorder. This study provides further confirmation of the additive benefits of medication when combined with CBT, and is also important in providing the clinician with predictors of response that will potentially help clinicians to determine the treatment option that is best suited to an individual patient.","journal-title":"J Am Acad Child Adolesc Psychiatry"}],"container-title":["Current Psychiatry Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-003-0054-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11920-003-0054-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-003-0054-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T17:07:24Z","timestamp":1587575244000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11920-003-0054-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,7]]},"references-count":95,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,7]]}},"alternative-id":["54"],"URL":"https:\/\/doi.org\/10.1007\/s11920-003-0054-9","relation":{},"ISSN":["1523-3812","1535-1645"],"issn-type":[{"value":"1523-3812","type":"print"},{"value":"1535-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,7]]}}}